Overview Financials News + Filings |
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-18 | Jun-30-17 | Jun-30-16 |
Revenues | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 |
Revenue growth | | | | 1599.1% | 234.1% | |
Cost of goods sold | -0.4 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.4 | 0.0 | -0.2 | 0.5 | 0.0 | 0.0 |
Gross margin | | | | 100.0% | 0.0% | 0.0% |
Research and development | | | | 0.3 | | |
General and administrative | 0.3 | 1.8 | 0.2 | 0.7 | 0.0 | 0.0 |
EBIT | -0.3 | -1.8 | -0.1 | -0.5 | 0.0 | 0.0 |
EBIT margin | | | | -101.3% | -100.0% | -100.0% |
Pre-tax income | -0.3 | -1.5 | -0.2 | -0.4 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -0.3 | -1.5 | 518.2 | -0.4 | 0.0 | 0.0 |
Net margin | | | | -69.9% | -21.9% | -100.0% |
|
Diluted EPS | $0.00 | $0.00 | $1.50 | $0.00 | $0.00 | $0.00 |
Shares outstanding (diluted) | 2,095.9 | 2,028.7 | 345.0 | 187.8 | 113.9 | 113.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|